Breaking News Instant updates and real-time market news.

AAXN

Axon

$73.83 /

-1.7 (-2.25%)

05:08
05/18/20
05/18
05:08
05/18/20
05:08

Axon price target raised to $82 from $78 at Imperial Capital

Imperial Capital analyst Jeff Kessler raised the firm's price target on Axon Enterprise to $82 from $78 and keeps an In-Line rating on the shares following the company's Q1 results. Axon's revenue continues to rebound from 2019 levels despite the current economy, Kessler tells investors in a research note.

  • 21

    May

  • 29

    May

  • 16

    Jun

AAXN Axon
$73.83 /

-1.7 (-2.25%)

03/02/20 Imperial Capital
Axon downgraded to In-Line from Outperform at Imperial Capital
02/28/20 Needham
Axon price target raised to $90 from $80 at Needham
02/24/20 JPMorgan
Axon price target raised to $92 from $78 at JPMorgan
02/24/20 JPMorgan
Axon price target raised to $92 from $78 at JPMorgan

TODAY'S FREE FLY STORIES

Initiation
Orphazyme initiated with a Buy at Guggenheim » 06:18
10/26/20
10/26
06:18
10/26/20
06:18
ORPH

Orphazyme

$10.06 /

-0.175 (-1.71%)

Guggenheim analyst Yatin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ORPH Orphazyme
$10.06 /

-0.175 (-1.71%)

06:12 Today BofA
Orphazyme initiated with a Buy at BofA
06:03 Today BofA
Orphazyme initiated with a Buy at BofA
  • 29
    Sep
ORPH Orphazyme
$10.06 /

-0.175 (-1.71%)

Earnings
Otis Worldwide reports Q3 adj. EPS 69c, consensus 56c » 06:18
10/26/20
10/26
06:18
10/26/20
06:18
OTIS

Otis Worldwide

$63.46 /

+0.175 (+0.28%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OTIS Otis Worldwide
$63.46 /

+0.175 (+0.28%)

OTIS Otis Worldwide
$63.46 /

+0.175 (+0.28%)

10/07/20 JPMorgan
Otis Worldwide price target raised to $79 from $75 at JPMorgan
09/24/20 Wolfe Research
Otis Worldwide upgraded to Outperform from Peer Perform at Wolfe Research
09/24/20 JPMorgan
Otis Worldwide pullback due to 'unwarranted concerns,' says JPMorgan
07/29/20 Credit Suisse
Otis Worldwide price target raised to $66 from $55 at Credit Suisse
OTIS Otis Worldwide
$63.46 /

+0.175 (+0.28%)

Recommendations
Husky Energy rating changed to Tenger from Sector Perform at National Bank » 06:16
10/26/20
10/26
06:16
10/26/20
06:16
HUSKF

Husky Energy

$0.00 /

+ (+0.00%)

, CVE

Cenovus Energy

$3.72 /

-0.03 (-0.80%)

National Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUSKF Husky Energy
$0.00 /

+ (+0.00%)

CVE Cenovus Energy
$3.72 /

-0.03 (-0.80%)

HUSKF Husky Energy
$0.00 /

+ (+0.00%)

10/20/20 Morgan Stanley
Husky Energy price target lowered to C$4 from C$6 at Morgan Stanley
10/16/20 National Bank
Husky Energy price target lowered to C$4 from C$6 at National Bank
09/03/20 Goldman Sachs
Husky Energy assumed with a Sell at Goldman Sachs
09/02/20 Barclays
Husky Energy initiated with an Equal Weight at Barclays
CVE Cenovus Energy
$3.72 /

-0.03 (-0.80%)

10/20/20 Morgan Stanley
Cenovus Energy price target lowered to C$6 from C$8 at Morgan Stanley
10/16/20 National Bank
Cenovus Energy price target lowered to C$8 from C$11 at National Bank
10/01/20
Fly Intel: Top five analyst downgrades
10/01/20 JPMorgan
Cenovus downgraded to Underweight on valuation, leverage at JPMorgan
HUSKF Husky Energy
$0.00 /

+ (+0.00%)

CVE Cenovus Energy
$3.72 /

-0.03 (-0.80%)

CVE Cenovus Energy
$3.72 /

-0.03 (-0.80%)

Upgrade
Kontoor Brands upgraded to Buy from Neutral at BofA » 06:15
10/26/20
10/26
06:15
10/26/20
06:15
KTB

Kontoor Brands

$32.62 /

+0.48 (+1.49%)

BofA analyst Heather…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KTB Kontoor Brands
$32.62 /

+0.48 (+1.49%)

KTB Kontoor Brands
$32.62 /

+0.48 (+1.49%)

06:04 Today BofA
Kontoor Brands upgraded to Buy from Underperform at BofA
10/13/20 Piper Sandler
Kontoor Brands price target raised to $36 from $29 at Piper Sandler
10/07/20 Barclays
Barclays upgrades Retail sector to Positive, makes seven rating changes
10/07/20 Barclays
Kontoor Brands upgraded to Overweight from Equal Weight at Barclays
KTB Kontoor Brands
$32.62 /

+0.48 (+1.49%)

Initiation
Pulmonx initiated with an Equal Weight at Wells Fargo » 06:14
10/26/20
10/26
06:14
10/26/20
06:14
LUNG

Pulmonx

$42.02 /

-0.61 (-1.43%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
  • 01
    Oct
LUNG Pulmonx
$42.02 /

-0.61 (-1.43%)

Recommendations
Turning Point Therapeutics price target raised to $130 from $100 at H.C. Wainwright » 06:13
10/26/20
10/26
06:13
10/26/20
06:13
TPTX

Turning Point Therapeutics

$102.72 /

+0.82 (+0.80%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TPTX Turning Point Therapeutics
$102.72 /

+0.82 (+0.80%)

TPTX Turning Point Therapeutics
$102.72 /

+0.82 (+0.80%)

10/25/20 Oppenheimer
Turning Point Therapeutics price target raised to $120 from $90 at Oppenheimer
09/21/20 H.C. Wainwright
Turning Point price target raised to $100 from $88 at H.C. Wainwright
08/21/20 Canaccord
Turning Point Therapeutics price target raised to $85 from $80 at Canaccord
08/19/20 Roth Capital
Turning Point Therapeutics price target raised to $77 from $75 at Roth Capital
TPTX Turning Point Therapeutics
$102.72 /

+0.82 (+0.80%)

  • 19
    May
Recommendations
Viela Bio price target lowered to $75 from $82 at H.C. Wainwright » 06:12
10/26/20
10/26
06:12
10/26/20
06:12
VIE

Viela Bio

$32.60 /

+0.62 (+1.94%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VIE Viela Bio
$32.60 /

+0.62 (+1.94%)

VIE Viela Bio
$32.60 /

+0.62 (+1.94%)

07/15/20 Goldman Sachs
Viela Bio upgraded to Neutral from Sell at Goldman Sachs
06/12/20 Piper Sandler
Piper says competitive updates present 'very little' potential impact on Alexion
06/12/20 H.C. Wainwright
Viela Bio price target raised to $76 from $70 at H.C. Wainwright
06/09/20
Fly Intel: Top five analyst initiations
VIE Viela Bio
$32.60 /

+0.62 (+1.94%)

  • 28
    May
Initiation
Orphazyme initiated with a Buy at BofA » 06:12
10/26/20
10/26
06:12
10/26/20
06:12
ORPH

Orphazyme

$10.06 /

-0.175 (-1.71%)

BofA analyst Tazeen Ahmad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORPH Orphazyme
$10.06 /

-0.175 (-1.71%)

06:03 Today BofA
Orphazyme initiated with a Buy at BofA
  • 29
    Sep
ORPH Orphazyme
$10.06 /

-0.175 (-1.71%)

Recommendations
Revolution Medicines price target raised to $54 from $52 at H.C. Wainwright » 06:11
10/26/20
10/26
06:11
10/26/20
06:11
RVMD

Revolution Medicines

$40.39 /

+1.17 (+2.98%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RVMD Revolution Medicines
$40.39 /

+1.17 (+2.98%)

RVMD Revolution Medicines
$40.39 /

+1.17 (+2.98%)

09/14/20 Jefferies
Inhibrx initiated with a Buy at Jefferies
05/21/20
Fly Intel: Top five analyst initiations
05/21/20 H.C. Wainwright
Revolution Medicines initiated with a Buy at H.C. Wainwright
03/09/20
Fly Intel: Top five analyst initiations
RVMD Revolution Medicines
$40.39 /

+1.17 (+2.98%)

  • 09
    Jul
  • 13
    Feb
RVMD Revolution Medicines
$40.39 /

+1.17 (+2.98%)

Initiation
Inter Pipeline initiated with an Equal Weight at Wells Fargo » 06:11
10/26/20
10/26
06:11
10/26/20
06:11
IPPLF

Inter Pipeline

$0.00 /

+ (+0.00%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IPPLF Inter Pipeline
$0.00 /

+ (+0.00%)

10/22/20 Canaccord
Inter Pipeline price target lowered to C$14 from C$16 at Canaccord
10/20/20 CIBC
Inter Pipeline price target raised to C$14 from C$13.50 at CIBC
09/29/20 Raymond James
Inter Pipeline price target raised to C$13 from C$12 at Raymond James
09/23/20 National Bank
Inter Pipeline price target raised to C$14 from C$13 at National Bank
Recommendations
Mirati Therapeutics price target raised to $238 from $222 at H.C. Wainwright » 06:10
10/26/20
10/26
06:10
10/26/20
06:10
MRTX

Mirati Therapeutics

$180.37 /

+0.13 (+0.07%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRTX Mirati Therapeutics
$180.37 /

+0.13 (+0.07%)

MRTX Mirati Therapeutics
$180.37 /

+0.13 (+0.07%)

05:07 Today Piper Sandler
Mirati Therapeutics price target raised to $210 from $170 at Piper Sandler
05:05 Today Piper Sandler
Amgen opportunity not diminished by Mirati data, says Piper Sandler
10/21/20 BMO Capital
Mirati Therapeutics price target raised to $176 from $101 at BMO Capital
10/08/20 Credit Suisse
Mirati Therapeutics price target raised to $190 from $140 at Credit Suisse
MRTX Mirati Therapeutics
$180.37 /

+0.13 (+0.07%)

  • 10
    Jan
Initiation
ImmunoGen assumed with a Buy at H.C. Wainwright » 06:09
10/26/20
10/26
06:09
10/26/20
06:09
IMGN

ImmunoGen

$5.46 /

-0.06 (-1.09%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMGN ImmunoGen
$5.46 /

-0.06 (-1.09%)

IMGN ImmunoGen
$5.46 /

-0.06 (-1.09%)

10/19/20 Piper Sandler
Greater China partnership 'very favorable' for ImmunoGen, says Piper Sandler
10/05/20 Piper Sandler
Piper says r/r BPDCN revenue opportunity for ImmunoGen's 632 'an open question'
10/02/20 Guggenheim
ImmunoGen upgraded to Buy from Neutral at Guggenheim
09/29/20 JPMorgan
ImmunoGen resumed with a Neutral at JPMorgan
IMGN ImmunoGen
$5.46 /

-0.06 (-1.09%)

  • 21
    Jan
IMGN ImmunoGen
$5.46 /

-0.06 (-1.09%)

Upgrade
TechnipFMC upgraded to Buy from Hold at Societe Generale » 06:08
10/26/20
10/26
06:08
10/26/20
06:08
FTI

TechnipFMC

$6.48 /

-0.385 (-5.61%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FTI TechnipFMC
$6.48 /

-0.385 (-5.61%)

FTI TechnipFMC
$6.48 /

-0.385 (-5.61%)

05:32 Today Societe Generale
TechnipFMC upgraded to Buy from Hold at Societe Generale
10/13/20 Jefferies
TechnipFMC upgraded to Hold from Underperform at Jefferies
10/01/20 BMO Capital
TechnipFMC initiated with a Market Perform at BMO Capital
08/07/20 HSBC
TechnipFMC downgraded to Hold from Buy at HSBC
FTI TechnipFMC
$6.48 /

-0.385 (-5.61%)

FTI TechnipFMC
$6.48 /

-0.385 (-5.61%)

FTI TechnipFMC
$6.48 /

-0.385 (-5.61%)

Initiation
Gibson Energy initiated with an Overweight at Wells Fargo » 06:08
10/26/20
10/26
06:08
10/26/20
06:08
GBNXF

Gibson Energy

$0.00 /

+ (+0.00%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GBNXF Gibson Energy
$0.00 /

+ (+0.00%)

GBNXF Gibson Energy
$0.00 /

+ (+0.00%)

09/10/20 Raymond James
Gibson Energy downgraded to Market Perform from Outperform at Raymond James
08/28/20 CIBC
NCIB makes sense for Gibson, says CIBC
08/06/20 CIBC
Gibson Energy price target raised to C$25 from C$24 at CIBC
08/06/20 RBC Capital
Gibson Energy price target raised to C$27 from C$25 at RBC Capital
Initiation
Asana initiated with a Neutral at Piper Sandler » 06:08
10/26/20
10/26
06:08
10/26/20
06:08
ASAN

Asana

$23.51 /

-0.48 (-2.00%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASAN Asana
$23.51 /

-0.48 (-2.00%)

ASAN Asana
$23.51 /

-0.48 (-2.00%)

05:12 Today Jefferies
Asana initiated with a Buy at Jefferies
10/08/20 Bernstein
Asana initiated with an Underperform at Bernstein
ASAN Asana
$23.51 /

-0.48 (-2.00%)

ASAN Asana
$23.51 /

-0.48 (-2.00%)

ASAN Asana
$23.51 /

-0.48 (-2.00%)

Hot Stocks
New Fortress Energy invests in green hydrogen production company H2Pro » 06:06
10/26/20
10/26
06:06
10/26/20
06:06
NFE

New Fortress Energy

$50.60 /

-3.05 (-5.68%)

New Fortress Energy has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFE New Fortress Energy
$50.60 /

-3.05 (-5.68%)

NFE New Fortress Energy
$50.60 /

-3.05 (-5.68%)

09/08/20 Credit Suisse
New Fortress Energy price target raised to $28 from $16 at Credit Suisse
08/26/20 Fearnley
New Fortress Energy initiated with a Buy at Fearnley
08/05/20 Citi
New Fortress Energy price target raised to $26 from $16 at Citi
07/22/20 Scotiabank
Scotiabank starts New Fortress Energy at Outperform with $25 price target
NFE New Fortress Energy
$50.60 /

-3.05 (-5.68%)

NFE New Fortress Energy
$50.60 /

-3.05 (-5.68%)

Hot Stocks
CytoDyn: Leronlimab shows promising response in two stroke patients » 06:06
10/26/20
10/26
06:06
10/26/20
06:06
CYDY

CytoDyn

$0.00 /

+ (+0.00%)

CytoDyn announced two…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CYDY CytoDyn
$0.00 /

+ (+0.00%)

CYDY CytoDyn
$0.00 /

+ (+0.00%)

07/06/20 H.C. Wainwright
CytoDyn downgraded to Neutral from Buy at H.C. Wainwright
04/28/20 H.C. Wainwright
CytoDyn price target raised to $4 from $3 at H.C. Wainwright
04/03/20 H.C. Wainwright
CytoDyn price target raised to $3 from $1.50 at H.C. Wainwright
12/19/19 H.C. Wainwright
CytoDyn price target raised to $1.50 from $1.00 at H.C. Wainwright
CYDY CytoDyn
$0.00 /

+ (+0.00%)

CYDY CytoDyn
$0.00 /

+ (+0.00%)

Downgrade
SAP downgraded to Neutral from Outperform at Exane BNP Paribas » 06:06
10/26/20
10/26
06:06
10/26/20
06:06
SAP

SAP

$149.68 /

+2.15 (+1.46%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAP SAP
$149.68 /

+2.15 (+1.46%)

SAP SAP
$149.68 /

+2.15 (+1.46%)

05:20 Today Exane BNP Paribas
SAP downgraded to Neutral from Outperform at Exane BNP Paribas
04:53 Today JPMorgan
SAP downgraded to Neutral from Overweight at JPMorgan
10/08/20 JPMorgan
SAP expected to give Qualtrics update with Q3 results, says JPMorgan
07/28/20 JPMorgan
SAP price target raised to EUR 160 from EUR 125 at JPMorgan
SAP SAP
$149.68 /

+2.15 (+1.46%)

SAP SAP
$149.68 /

+2.15 (+1.46%)

SAP SAP
$149.68 /

+2.15 (+1.46%)

Recommendations
WesBanco price target raised to $29 from $26 at Piper Sandler » 06:06
10/26/20
10/26
06:06
10/26/20
06:06
WSBC

WesBanco

$24.89 /

-0.33 (-1.31%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WSBC WesBanco
$24.89 /

-0.33 (-1.31%)

WSBC WesBanco
$24.89 /

-0.33 (-1.31%)

09/24/20 Boenning & Scattergood
WesBanco resumed with an Outperform at Boenning & Scattergood
07/09/20 Piper Sandler
WesBanco resumed with an Overweight at Piper Sandler
06/17/20 Raymond James
WesBanco upgraded to Outperform from Market Perform at Raymond James
06/17/20 Raymond James
WesBanco upgraded to Outperform from Market Perform at Raymond James
WSBC WesBanco
$24.89 /

-0.33 (-1.31%)

Downgrade
Exelon downgraded to Neutral from Buy at Guggenheim » 06:05
10/26/20
10/26
06:05
10/26/20
06:05
EXC

Exelon

$42.20 /

-0.03 (-0.07%)

Guggenheim analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EXC Exelon
$42.20 /

-0.03 (-0.07%)

EXC Exelon
$42.20 /

-0.03 (-0.07%)

10/14/20 Mizuho
Exelon restructuring has 'big obstacles' says Mizuho
08/24/20 Morgan Stanley
Morgan Stanley says Illinois Governor's energy principles positive for Exelon
08/17/20
Fly Intel: Top five analyst downgrades
08/17/20 BofA
Exelon downgraded to Underperform from Neutral at BofA
EXC Exelon
$42.20 /

-0.03 (-0.07%)

EXC Exelon
$42.20 /

-0.03 (-0.07%)

EXC Exelon
$42.20 /

-0.03 (-0.07%)

EXC Exelon
$42.20 /

-0.03 (-0.07%)

Upgrade
Kontoor Brands upgraded to Buy from Underperform at BofA » 06:04
10/26/20
10/26
06:04
10/26/20
06:04
KTB

Kontoor Brands

$32.62 /

+0.48 (+1.49%)

BofA upgraded Kontoor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KTB Kontoor Brands
$32.62 /

+0.48 (+1.49%)

KTB Kontoor Brands
$32.62 /

+0.48 (+1.49%)

10/13/20 Piper Sandler
Kontoor Brands price target raised to $36 from $29 at Piper Sandler
10/07/20 Barclays
Barclays upgrades Retail sector to Positive, makes seven rating changes
10/07/20 Barclays
Kontoor Brands upgraded to Overweight from Equal Weight at Barclays
09/29/20 Goldman Sachs
Kontoor Brands price target raised to $29 from $24 at Goldman Sachs
KTB Kontoor Brands
$32.62 /

+0.48 (+1.49%)

Periodicals
Fitbit still sees acquisition by Google closing in 2020, WSJ reports » 06:03
10/26/20
10/26
06:03
10/26/20
06:03
FIT

Fitbit

$6.96 /

+0.015 (+0.22%)

, GOOG

Alphabet

$1,640.50 /

+25.89 (+1.60%)

, GOOGL

Alphabet Class A

$1,632.77 /

+24.75 (+1.54%)

Fitbit (FIT) co-founder…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FIT Fitbit
$6.96 /

+0.015 (+0.22%)

GOOG Alphabet
$1,640.50 /

+25.89 (+1.60%)

GOOGL Alphabet Class A
$1,632.77 /

+24.75 (+1.54%)

FIT Fitbit
$6.96 /

+0.015 (+0.22%)

06/19/20 Deutsche Bank
Fitbit acquisition completing remains base case at Deutsche Bank
11/27/19 Deutsche Bank
Second Fitbit suitor should limit downside if deal breaks, says Deutsche Bank
11/06/19 DA Davidson
Sonos rallies after DA Davidson calls 'natural acquisition target' for Apple
11/04/19 DA Davidson
Fitbit downgraded to Neutral from Buy at DA Davidson
GOOG Alphabet
$1,640.50 /

+25.89 (+1.60%)

10/23/20 Cleveland Research
Alphabet upgraded to Buy on Search, Cloud momentum at Cleveland Research
10/22/20 Jefferies
Jefferies says 71% of Google users would still use search if removed from device
10/21/20 JPMorgan
Alphabet arguments against lawsuit have merits, says JPMorgan
10/21/20 Morgan Stanley
Slack downgraded to Underweight on rising competitive risk at Morgan Stanley
GOOGL Alphabet Class A
$1,632.77 /

+24.75 (+1.54%)

10/23/20 Cleveland Research
Alphabet upgraded to Buy on Search, Cloud momentum at Cleveland Research
10/23/20 Cleveland Research
Alphabet Class A upgraded to Buy from Neutral at Cleveland Research
10/22/20 Jefferies
Jefferies says 71% of Google users would still use search if removed from device
10/21/20 JPMorgan
Alphabet arguments against lawsuit have merits, says JPMorgan
FIT Fitbit
$6.96 /

+0.015 (+0.22%)

GOOG Alphabet
$1,640.50 /

+25.89 (+1.60%)

GOOGL Alphabet Class A
$1,632.77 /

+24.75 (+1.54%)

FIT Fitbit
$6.96 /

+0.015 (+0.22%)

GOOG Alphabet
$1,640.50 /

+25.89 (+1.60%)

GOOGL Alphabet Class A
$1,632.77 /

+24.75 (+1.54%)

FIT Fitbit
$6.96 /

+0.015 (+0.22%)

GOOG Alphabet
$1,640.50 /

+25.89 (+1.60%)

GOOGL Alphabet Class A
$1,632.77 /

+24.75 (+1.54%)

FIT Fitbit
$6.96 /

+0.015 (+0.22%)

GOOGL Alphabet Class A
$1,632.77 /

+24.75 (+1.54%)

GOOGL Alphabet Class A
$1,632.77 /

+24.75 (+1.54%)

Hot Stocks
BMW, Alibaba sign MOU for strategic partnership in Beijing » 06:03
10/26/20
10/26
06:03
10/26/20
06:03
BMWYY

BMW

$0.00 /

+ (+0.00%)

, BABA

Alibaba

$309.95 /

+3.56 (+1.16%)

BMW (BMWYY) and Alibaba…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMWYY BMW
$0.00 /

+ (+0.00%)

BABA Alibaba
$309.95 /

+3.56 (+1.16%)

BMWYY BMW
$0.00 /

+ (+0.00%)

10/15/20 UBS
BMW price target raised to EUR 65 from EUR 60 at UBS
10/13/20 Commerzbank
BMW downgraded to Hold from Buy at Commerzbank
10/07/20 Societe Generale
BMW price target raised to EUR 75 from EUR 68 at Societe Generale
10/02/20 Deutsche Bank
BMW price target raised to EUR 70 from EUR 60 at Deutsche Bank
BABA Alibaba
$309.95 /

+3.56 (+1.16%)

10/20/20 Barclays
Alibaba price target raised to $360 from $320 at Barclays
10/20/20 Oppenheimer
Oppenheimer starts Pinduoduo with Outperform, $100 price target
10/13/20 China Renaissance
Alibaba price target raised to $355 from $315 at China Renaissance
10/06/20 Goldman Sachs
Alibaba price target raised to $350 from $315 at Goldman Sachs
BMWYY BMW
$0.00 /

+ (+0.00%)

BABA Alibaba
$309.95 /

+3.56 (+1.16%)

BMWYY BMW
$0.00 /

+ (+0.00%)

BABA Alibaba
$309.95 /

+3.56 (+1.16%)

BABA Alibaba
$309.95 /

+3.56 (+1.16%)

BABA Alibaba
$309.95 /

+3.56 (+1.16%)

Initiation
Orphazyme initiated with a Buy at BofA » 06:03
10/26/20
10/26
06:03
10/26/20
06:03
ORPH

Orphazyme

$10.06 /

-0.175 (-1.71%)

BofA initiated coverage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 29
    Sep
ORPH Orphazyme
$10.06 /

-0.175 (-1.71%)

Hot Stocks
Armada Hoffler reclaims two sites for redevelopment in Virginia » 06:03
10/26/20
10/26
06:03
10/26/20
06:03
AHH

Armada Hoffler

$8.96 /

+0.16 (+1.82%)

Armada Hoffler has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AHH Armada Hoffler
$8.96 /

+0.16 (+1.82%)

AHH Armada Hoffler
$8.96 /

+0.16 (+1.82%)

06/25/20 Stifel
Armada Hoffler upgraded to Hold from Sell at Stifel
04/27/20 BofA
Armada Hoffler downgraded to Neutral from Buy at BofA
04/27/20 BofA
Armada Hoffler downgraded to Neutral from Buy at BofA
04/12/20 Stifel
Armada Hoffler downgraded to Sell from Hold at Stifel
AHH Armada Hoffler
$8.96 /

+0.16 (+1.82%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.